REQUEST A DEMO
Total
USD $0.00
Search more companies

Merck Bulgaria EAD (Bulgaria)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Merck Bulgaria EAD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Merck Bulgaria EAD wa sestablished in 2009. The company is part of German Merck - a science and technology company in healthcare, life science and performance materials, which set foot on the Bulgarian market in 1992 by establishing a representative office. The Sofia-based entity is engaged in the wholesale distribution of pharmaceuticals and chemical products.

Headquarters
zh.k. Serdika Offices , Sitnyakovo 48, et. 6
Sofia; Sofia - city; Postal Code: 1505

Contact Details: Purchase the Merck Bulgaria EAD report to view the information.

Website: http://www.merck.bg

Basic Information
Total Employees:
Purchase the Merck Bulgaria EAD report to view the information.
Outstanding Shares:
Purchase the Merck Bulgaria EAD report to view the information.
Registered Capital:
Purchase the Merck Bulgaria EAD report to view the information.
Financial Auditors:
Purchase the Merck Bulgaria EAD report to view the information.
Incorporation Date:
September 01, 2009
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Merck Bulgaria EAD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
4.71%
Total operating revenue
4.73%
Operating profit (EBIT)
152.51%
EBITDA
81.04%
Net Profit (Loss) for the Period
168.49%
Total assets
1.71%
Total equity
16.11%
Operating Profit Margin (ROS)
2.36%
Net Profit Margin
2.06%
Return on Equity (ROE)
7.87%
Quick Ratio
0.22%
Cash Ratio
0.4%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?